Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TARO-CAPECITABINE TARO PHARMACEUTICALS INC Resolved 150MG Updated Report 2025-12-17 273667
PROCYTOX TAB 50MG BAXTER CORPORATION Resolved 50MG Updated Report 2025-12-17 274446
VESICARE ASTELLAS PHARMA CANADA INC Anticipated shortage 5MG Updated Report 2025-12-17 267784
VESICARE ASTELLAS PHARMA CANADA INC Anticipated shortage 10MG Updated Report 2025-12-17 267787
BIVALIRUDIN INJECTION AVIR PHARMA INC. Anticipated shortage 5MG Updated Report 2025-12-16 274457
MYXREDLIN BAXTER CORPORATION Actual shortage 1UNIT Updated Report 2025-12-16 272638
UROMITEXAN BAXTER CORPORATION Actual shortage 100MG Updated Report 2025-12-16 274386
PMS-FLUOXETINE PHARMASCIENCE INC Resolved 60MG Updated Report 2025-12-16 270554
SODIUM CHLORIDE IRRIGATION USP ICU MEDICAL CANADA INC Actual shortage 9MG Updated Report 2025-12-16 269398
XYLOCAINE 1% ASPEN PHARMACARE CANADA INC. Actual shortage 10MG New Report 2025-12-16 274438

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
VESICARE ASTELLAS PHARMA CANADA INC To be discontinued 10MG New Report 2025-12-17 274468
VESICARE ASTELLAS PHARMA CANADA INC To be discontinued 5MG New Report 2025-12-17 274465
TARO-CLOBETASOL OINTMENT USP, 0.05% TARO PHARMACEUTICALS INC Discontinued 0.05% Updated Report 2025-12-13 274315
CEFTRIAXONE SODIUM FOR INJECTION BP STERIMAX INC To be discontinued 250MG New Report 2025-12-11 274173
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP STERIMAX INC To be discontinued 7.5MG New Report 2025-12-11 274162